<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>1141</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>15971273</PubmedId>
            <Abstract>Antibody phage display technology was used to identify human monoclonal antibodies that neutralize rabies virus (RV). A phage repertoire was constructed using antibody genes harvested from the blood of vaccinated donors. Selections using this repertoire and three different antigen formats of the RV glycoprotein (gp) resulted in the identification of 147 unique antibody fragments specific for the RV gp. Analysis of the DNA sequences of these antibodies demonstrated a large variation in the heavy- and light-chain germ-line gene usage, suggesting that a broad antibody repertoire was selected. The single-chain variable fragment (scFv) antibodies were tested in vitro for RV neutralization, resulting in 39 specificities that neutralize the virus. Of the scFv clones, 21 were converted into full-length human IgG(1) format. Analysis of viral escape variants and binding competition experiments indicated that the majority of the neutralizing antibodies are directed against antigenic site III of the RV gp. The obtained specificities expand the set of human anti-RV antibodies eligible for inclusion in an antibody cocktail aimed for use in rabies post-exposure prophylaxis.</Abstract>
            <ArticleYear>2005</ArticleYear>
            <ArticlePages>2131-45</ArticlePages>
            <ArticleTitle>The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Kramer</LastName>
                    <ForeName>R Arjen</ForeName>
                </Author>
                <Author>
                    <LastName>Marissen</LastName>
                    <ForeName>Wilfred E</ForeName>
                </Author>
                <Author>
                    <LastName>Goudsmit</LastName>
                    <ForeName>Jaap</ForeName>
                </Author>
                <Author>
                    <LastName>Visser</LastName>
                    <ForeName>Therese J</ForeName>
                </Author>
                <Author>
                    <LastName>Clijsters-Van der Horst</LastName>
                    <ForeName>Marieke</ForeName>
                </Author>
                <Author>
                    <LastName>Bakker</LastName>
                    <ForeName>Arjen Q</ForeName>
                </Author>
                <Author>
                    <LastName>de Jong</LastName>
                    <ForeName>Maureen</ForeName>
                </Author>
                <Author>
                    <LastName>Jongeneelen</LastName>
                    <ForeName>Mandy</ForeName>
                </Author>
                <Author>
                    <LastName>Thijsse</LastName>
                    <ForeName>Sandra</ForeName>
                </Author>
                <Author>
                    <LastName>Backus</LastName>
                    <ForeName>Harold H J</ForeName>
                </Author>
                <Author>
                    <LastName>Rice</LastName>
                    <ForeName>Amy B</ForeName>
                </Author>
                <Author>
                    <LastName>Weldon</LastName>
                    <ForeName>William C</ForeName>
                </Author>
                <Author>
                    <LastName>Rupprecht</LastName>
                    <ForeName>Charles E</ForeName>
                </Author>
                <Author>
                    <LastName>Dietzschold</LastName>
                    <ForeName>Bernhard</ForeName>
                </Author>
                <Author>
                    <LastName>Bakker</LastName>
                    <ForeName>Alexander B H</ForeName>
                </Author>
                <Author>
                    <LastName>de Kruif</LastName>
                    <ForeName>John</ForeName>
                </Author>
            </Authors>
            <Affiliations>Crucell Holland B.V., Leiden, The Netherlands.</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Antibodies, Viral;Antigens, Viral;Glycoproteins;Immunoglobulin Fragments;Immunoglobulin G;Immunoglobulin Variable Region;Peptide Library;Viral Envelope Proteins;glycoprotein G, Rabies virus</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Antibodies, Monoclonal(analysis; metabolism); Antibodies, Viral(analysis; biosynthesis; metabolism); Antigens, Viral(immunology); Glycoproteins(immunology); Humans; Immunoglobulin Fragments(analysis; biosynthesis); Immunoglobulin G(analysis; biosynthesis; metabolism); Immunoglobulin Variable Region(analysis; biosynthesis); Molecular Sequence Data; Peptide Library; Peptide Mapping; Rabies virus(immunology); Viral Envelope Proteins(immunology)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>35</Volume>
                <Issue>7</Issue>
                <Title>European journal of immunology</Title>
                <Issn>0014-2980</Issn>
                <MedlineTa>Eur J Immunol</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>318-324</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>FNKTLME</LinearSequence>
                        <StartingPosition>337</StartingPosition>
                        <EndingPosition>343</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>P03524.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>11295</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Page 2005</LocationOfData>
                <EpitopeId>17187</EpitopeId>
                <ReferenceStartingPosition>318</ReferenceStartingPosition>
                <ReferenceEndingPosition>324</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <EpitopeComments>Possibly corresponding to the previously defined antigenic site III since escape mutants at that antigenic site are not neutralized by neutralizing mAb recognizing this epitope. Swiss-prot ID and positions correspond to the Spike glycoprotein precursor.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Text</LocationOfData>
                        <BCellId>15927</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11295</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Rabies vaccinated healthy donors were the source of cDNA for scFv library construction.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>An IgG1 molecule reconstructed from a scFv monoclonal antibody selected from a immune human library (constructed from vaccinated donors) by its ability to bind source protein, recognizes this epitope in a PEPSCAN analysis.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>CR4010</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>318-324</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FNKTLME</LinearSequence>
                                        <StartingPosition>337</StartingPosition>
                                        <EndingPosition>343</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03524.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11295</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 10B</LocationOfData>
                        <BCellId>15928</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9606</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>11295</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Rabies vaccinated healthy donors were the source of cDNA for scFv library construction.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>An IgG1 molecule reconstructed from a scFv monoclonal antibody selected from an immune human library (constructed from vaccinated donors) by its ability to bind to the source protein and shown to bind this epitope, loses its ability to neutralize virus escape mutants with mutations at antigenic site III, implying this epitope may be part of this previously identified antigenic site.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>CR4010</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>318-324</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>FNKTLME</LinearSequence>
                                        <StartingPosition>337</StartingPosition>
                                        <EndingPosition>343</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>P03524.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>11295</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

